Qiagen N.V. — Director's Dealing 2007

Jun 19, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: eGENE, INC. (EGEI)
CIK: 0001105409
Period of Report: 2007-06-15

Reporting Person: QIAGEN NV (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-06-15	Common Stock	P	10000	$1.35	Acquired	712500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5902205	Indirect

Footnotes

F1: As of the date hereof, QIAGEN North American Holdings, Inc. ("Holdings"), a wholly-owned subsidiary of QIAGEN N.V., a Dutch public limited liability company ("QIAGEN"), is party to voting agreements dated as of April 12, 2007 (the "Voting Agreements"), with each of the directors and executive officers of eGene, Inc. ("eGene") and certain other stockholders of eGene, which Voting Agreements were entered into in connection with the Agreement and Plan of Merger, dated as of April 12, 2007 (the "Merger Agreement"), among Holdings, Electra Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary of Holdings, and eGene. Pursuant to the Voting Agreements, Holdings has been granted a proxy to vote the 5,902,205 shares of eGene common stock that are subject to the Voting Agreements (collectively, the "Shares") on all matters relating to the merger. Accordingly, QIAGEN may be deemed to beneficially own an aggregate of 5,902,205 Shares.